BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02969525-completion@plaintrial.com
DTSTAMP:20261028T033336Z
DTSTART;VALUE=DATE:201807
SUMMARY:A Study to Evaluate the Dose Response Based on the Efficacy\, Safet
 y and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthri
 tis Which is a Type of Inflammatory Arthritis — estimated completion dat
 e
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02969525
URL:https://plaintrial.com/trial/NCT02969525
END:VEVENT
END:VCALENDAR